DDAVP in acquired hemophilia A: Case report and review of the literature

Raja Mudad, W. H. Kane

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

One patient with an acquired factor VIII inhibitor is reported in which an acute lower intestinal hemorrhage was successfully managed using Desmopressin (DDAVP). The patient initially had a factor VIII level of 10% with an inhibitor titer of 1.9 Bethesda units. Following administration of DDAVP the factor VIII level rose to 86% and there was a decrease in the number and volume of bloody stools. The inhibitor disappeared following treatment with corticosteroids, however the patient ultimately expired due to complications of ischemic colitis. This case and 21 previously reported cases of acquired hemophilia treated with DDAVP are reviewed. The data support a role for DDAVP in the treatment of non life threatening hemorrhage in patients with acquired hemophilia and low titer factor VIII inhibitors (<5 Bethesda units or factor VIII ≥5%).

Original languageEnglish (US)
Pages (from-to)295-299
Number of pages5
JournalAmerican Journal of Hematology
Volume43
Issue number4
StatePublished - 1993
Externally publishedYes

Fingerprint

Deamino Arginine Vasopressin
Factor VIII
Hemophilia A
Ischemic Colitis
Hemorrhage
Adrenal Cortex Hormones
Acquired Factor 8 deficiency
Therapeutics

Keywords

  • acquired hemophilia
  • DDAVP
  • factor VIII inhibitor

ASJC Scopus subject areas

  • Hematology

Cite this

DDAVP in acquired hemophilia A : Case report and review of the literature. / Mudad, Raja; Kane, W. H.

In: American Journal of Hematology, Vol. 43, No. 4, 1993, p. 295-299.

Research output: Contribution to journalArticle

@article{b47f3c88438043d8aed6122c4a7b77d9,
title = "DDAVP in acquired hemophilia A: Case report and review of the literature",
abstract = "One patient with an acquired factor VIII inhibitor is reported in which an acute lower intestinal hemorrhage was successfully managed using Desmopressin (DDAVP). The patient initially had a factor VIII level of 10{\%} with an inhibitor titer of 1.9 Bethesda units. Following administration of DDAVP the factor VIII level rose to 86{\%} and there was a decrease in the number and volume of bloody stools. The inhibitor disappeared following treatment with corticosteroids, however the patient ultimately expired due to complications of ischemic colitis. This case and 21 previously reported cases of acquired hemophilia treated with DDAVP are reviewed. The data support a role for DDAVP in the treatment of non life threatening hemorrhage in patients with acquired hemophilia and low titer factor VIII inhibitors (<5 Bethesda units or factor VIII ≥5{\%}).",
keywords = "acquired hemophilia, DDAVP, factor VIII inhibitor",
author = "Raja Mudad and Kane, {W. H.}",
year = "1993",
language = "English (US)",
volume = "43",
pages = "295--299",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - DDAVP in acquired hemophilia A

T2 - Case report and review of the literature

AU - Mudad, Raja

AU - Kane, W. H.

PY - 1993

Y1 - 1993

N2 - One patient with an acquired factor VIII inhibitor is reported in which an acute lower intestinal hemorrhage was successfully managed using Desmopressin (DDAVP). The patient initially had a factor VIII level of 10% with an inhibitor titer of 1.9 Bethesda units. Following administration of DDAVP the factor VIII level rose to 86% and there was a decrease in the number and volume of bloody stools. The inhibitor disappeared following treatment with corticosteroids, however the patient ultimately expired due to complications of ischemic colitis. This case and 21 previously reported cases of acquired hemophilia treated with DDAVP are reviewed. The data support a role for DDAVP in the treatment of non life threatening hemorrhage in patients with acquired hemophilia and low titer factor VIII inhibitors (<5 Bethesda units or factor VIII ≥5%).

AB - One patient with an acquired factor VIII inhibitor is reported in which an acute lower intestinal hemorrhage was successfully managed using Desmopressin (DDAVP). The patient initially had a factor VIII level of 10% with an inhibitor titer of 1.9 Bethesda units. Following administration of DDAVP the factor VIII level rose to 86% and there was a decrease in the number and volume of bloody stools. The inhibitor disappeared following treatment with corticosteroids, however the patient ultimately expired due to complications of ischemic colitis. This case and 21 previously reported cases of acquired hemophilia treated with DDAVP are reviewed. The data support a role for DDAVP in the treatment of non life threatening hemorrhage in patients with acquired hemophilia and low titer factor VIII inhibitors (<5 Bethesda units or factor VIII ≥5%).

KW - acquired hemophilia

KW - DDAVP

KW - factor VIII inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0027216670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027216670&partnerID=8YFLogxK

M3 - Article

C2 - 8372811

AN - SCOPUS:0027216670

VL - 43

SP - 295

EP - 299

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -